Apeloa Pharmaceutical Co.,Ltd

¥21.48As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000739Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 12.39%
Div yield 1.29%
ROE 12.44%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.47
PE TTM 30.83
TSR TTM 40.70%
Mkt cap ¥24.14B
ROIC 15.14%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
4.54%
(76.56%)
Sell 5|5|8|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.31
0.33
0.33
0.35
13.14%
14.97%
7.89%
8.56%
Revenue¥B
1.690
1.677
1.742
1.691
20.01%
13.42%
11.58%
4.74%
Peers (US$3.618B)
Cap (US$)
PE
3.934B
28.04x
Capital
TTM
5Y
10Y
Leveragex
0.614
0.024
0.029
EBIT/Intx
9.733
0.412
0.371
Own earn%
26.92
151.51
150.89
Sh yield%
41.81
2.71
2.58
Owners
Insiders/Inst%
7.13
34.00
Short interest%
5.91
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
8–13
$1 testx
—
Incr. ROIC%
30